HTGM
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
HTGM
Delisted
HTGM was delisted on the 14th of June, 2023.
21 hedge funds and large institutions have $3.19M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.16M | |
| 2 | +$38K | |
| 3 | +$17K | |
| 4 |
Citigroup
New York
|
+$4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.63K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$776K | |
| 3 | -$363K | |
| 4 |
SC
Samjo Capital
New York
|
-$257K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$68.1K |